Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.
about
The risks of overlooking the diagnosis of secreting pituitary adenomasGlucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study.Pegvisomant in acromegaly: an update.Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV riskAcromegaly with cardiomyopathy, cardiac thrombus and hemorrhagic cerebral infarct: a case report of therapeutic dilemma with review of literature.Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.Pegvisomant in acromegaly: why, when, how.Somatostatin agonists for treatment of acromegaly.Octreotide LAR: safety and tolerability issues.Octreotide long-acting repeatable for acromegaly.Adverse events associated with somatostatin analogs in acromegaly.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy.Managing impaired glucose metabolism in acromegalic subjects.[Cardiovascular disturbances in acromegaly].Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study.Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues.Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.
P2860
Q28076665-7EC69466-D854-4788-8E06-36DDC9BB3384Q31144045-F68D6442-0F3C-46C2-B3C5-82357FA7EC51Q33725999-A7522C5D-FE7B-470E-B2D3-59D5E00CD08BQ34468089-36824B5F-5E43-446D-9947-9ED11AEF8931Q35428187-D131B58A-8EED-4C38-9A43-252EFA25369FQ36119677-FE8E1BCF-8006-460C-826F-09B854762F24Q36965612-51611633-0DBF-49C8-AAD2-DCBA1EF9C12BQ37055643-DD80BF99-6672-407E-90BF-FAC5A399E28DQ37649647-2324A3F4-B038-4A97-93A0-5B97F3BA0C3DQ37990556-C3DC63DD-00E0-4417-BCD5-805149003E20Q38548973-8169C7C9-71FB-48D2-8AD6-BACE9C6C7CD8Q38683309-F36FD828-8743-404A-BE2F-F378A5BD3330Q39146196-366C5C99-6D43-40EB-892B-3EAD828A494BQ40912187-EE0D9319-A888-4E5F-9EAA-97E7A4477761Q43222345-ECB6A77A-FFB7-400B-A18A-BFF07952EFA2Q45922646-5D1745A9-2F50-4271-8816-AA90A73A7B24Q46131364-7BC74D41-7210-4DB7-89EB-88B866434962Q51299912-ECC5559F-A474-40AD-8F5A-4BE22B666CB2Q51364801-DB8A4F37-8A5B-4527-9007-0AFD496CCD68Q51374462-BD6C66CD-009A-4E66-81D5-3685663F3951Q51750907-10FBB053-B1E1-4B86-8784-54CB17DF19B6
P2860
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comparison between six-year th ...... n cardiovascular risk factors.
@en
Comparison between six-year th ...... n cardiovascular risk factors.
@nl
type
label
Comparison between six-year th ...... n cardiovascular risk factors.
@en
Comparison between six-year th ...... n cardiovascular risk factors.
@nl
prefLabel
Comparison between six-year th ...... n cardiovascular risk factors.
@en
Comparison between six-year th ...... n cardiovascular risk factors.
@nl
P2093
P50
P356
P1476
Comparison between six-year th ...... n cardiovascular risk factors.
@en
P2093
Andrea Lania
Anna Spada
Francesca Donadio
Maura Arosio
Paolo Beck-Peccoz
Virginia Varca
P304
P356
10.1210/JC.2005-1704
P407
P577
2005-11-01T00:00:00Z